FDA -- Heart Failure Collaboratory (R18) Clinical Trials Optional

Funding Agency:
National Institutes of Health

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), Division of Cardiovascular and Renal Products (DCRP) is announcing its intent to accept and consider applications for the award of a grant to support the Heart Failure Collaboratory.

The goals of this program are to support the creation and execution of a series of research projects under the auspices of HFC, to complement the goals of FDA


  • Letter of Intent Due Date(s): December 22, 2019
  • Application Due Date(s): January 22, 2020

RFA-FD-20-005 Expiration Date January 23, 2020

Agency Website

Amount Description

YR 01: $150,000

YR 02: $500,000

YR 03: $500,000

YR 04: $500,000

YR 05: $500,000

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

January 22, 2020